InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
62,985.28
(
-1.18%
)
Post# of 63665
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Penny Roger$

Send PM Follow Ignore
Followers 1106
Posts 279775
Boards Moderated 10
Alias Born 03/18/2011

Penny Roger$

Re: None

Saturday, 12/20/2014 5:13:11 PM

Saturday, December 20, 2014 5:13:11 PM

Post# of 63665
Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients
| 6:30 AM |

[Business Wire] - Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it submitted an Investigational New Drug application to the U.S.

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/arrowhead-files-ind-rnai-therapeutic-123000470.html

~ Market News! ~

This news update brought to you by StockGoodies SizzlingStockPicks PennyStockTweets WallStreetSurfers and PennyStockMobsters.
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
http://www.stockgoodies.com/chart-school.html


St. Jude 2014 >> http://tinyurl.com/St-Jude-2014
http://www.fallenheroesfund.org/ ~

Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up